Evaluation of Abicipar Pegol
Evaluation of Abicipar Pegol
About this item
Full title
Evaluation of Abicipar Pegol
Author / Creator
Publisher
Slack, Inc
Journal title
Ophthalmic surgery, lasers & imaging retina, 2019-02, Vol.50 (2), p.E10
Language
English
Formats
Publication information
Publisher
Slack, Inc
Subjects
More information
Scope and Contents
Contents
BACKGROUND AND OBJECTIVE: To evaluate comparability of abicipar pegol (abicipar) effects in patients with treatment-naïve neovascular age-related macular degeneration (nAMD) in Japan and the United States. PATIENTS AND METHODS: Phase 2, multicenter, randomized, double-masked, 20-week studies (BAMBOO, Japan; CYPRESS, United States). Patients (n = 25...
Alternative Titles
Full title
Evaluation of Abicipar Pegol
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_healthsolutions_A713238498
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_healthsolutions_A713238498
Other Identifiers
ISSN
2325-8160
How to access this item
Log in as a Library member
